Alteogen, Biosimilar (Generic Biopharmaceutical) Theme Rises 10.68%

On the 5th, the biosimilar (replicated biopharmaceutical) theme rose 3.05% compared to the previous day, showing strength, while Alteogen, which is attracting attention as a related stock, surged 10.68% compared to the previous day. Alteogen is known as a biosimilar developer.

[Graph] Major stock price changes in the biosimilar (replicated biopharmaceutical) theme



According to provisional data compiled at 12:56, institutions are net selling 13,000 shares of Alteogen.

[Table] Foreigners and institutions net trading volume (unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, Alteogen’s quant financial score is 39.88 points, ranking 8th within the biosimilar (replicated biopharmaceutical) theme, with higher growth and profitability scores than the average of other related stocks. This indicates that compared to other stocks in the theme, Alteogen’s sales and net income growth rates are relatively fast, and its efficient profit-generating ability is also favorable.

[Table] Top financial scores within the theme


※ The quant financial score is the result of the Robo Algorithm analyzing each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.